Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Vedolizumab_VII.

This procurement notice was published by Institut klinické a experimentální medicíny in Czech Republic on 2026-02-13. The contract covers Medicalservices under CPV classification 33652300, 33652300, and follows a open procedure in accordance with EU Directive 2014/24/EU. The estimated contract value is €100,551,000. The submission deadline is 03/17/2026. This notice is open to all qualified suppliers across EU member states and is sourced directly from TED Europa — the official EU procurement journal.